Decipher is now part of Veracyte!     Learn More
Decipher is now part of Veracyte!     Learn More
Skip to content
PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis
New findings presented at ATS 2021 Conference also suggest novel test can be successfully enabled on nCounter Analysis System to support international expansion SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 14, 2021-- Veracyte, Inc . (Nasdaq: VCYT) announced that data reinforcing the
View HTML
Toggle Summary Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 14, 2021-- Veracyte, Inc . (Nasdaq: VCYT) announced today new data demonstrating the ability of the Percepta ® Genomic Atlas to detect alterations that may inform lung cancer treatment decisions for patients from the same small biopsy that was used
View HTML
Toggle Summary Veracyte, Inc. Announces CEO Succession Plan
Bonnie Anderson , Cofounder and CEO, to Assume Active Role as Executive Chairman; Marc Stapley to Become Chief Executive Officer SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 10, 2021-- Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced its executive
View HTML
Toggle Summary Veracyte Announces First Quarter 2021 Financial Results
Total Revenue of $36.7 Million Increased 18%; Volume Grew 11% to 14,437 Tests Completed Acquisition of Decipher Biosciences, Expanding Reach Into 7 of the Top 10 Cancers in the United States Pivotal Validation Data for Percepta Nasal Swab Lung Cancer Test To Be Presented at ASCO Conference Call and
View HTML
Toggle Summary Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 4, 2021-- Veracyte, Inc . (Nasdaq: VCYT) announced today that new data relating to the Prosigna ® Breast Cancer Gene Signature Assay will be presented at the European Society of Medical Oncology (ESMO) Breast Cancer Virtual Congress 2021 taking
View HTML
Toggle Summary Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO
- Pivotal clinical validation data for Percepta Nasal Swab test in early lung cancer detection - - New data demonstrating ability of Decipher Prostate test to identify high metastasis risk in African American men - SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Apr. 29, 2021-- Veracyte, Inc .
View HTML
Toggle Summary Veracyte Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Apr. 27, 2021-- Veracyte, Inc . (Nasdaq: VCYT) announced today the publication of a new study that demonstrates the robust performance of the Percepta Genomic Sequencing Classifier (GSC), a novel genomic test, in helping to improve lung cancer
View HTML
Toggle Summary Veracyte to Release First Quarter 2021 Financial Results on May 10, 2021
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Apr. 20, 2021-- Veracyte, Inc . (Nasdaq: VCYT) announced today that it will release its full financial results for the first quarter of 2021 after the close of market on Monday, May 10 . Company management will host a conference call and webcast to
View HTML
Toggle Summary Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference
- New data support role of Percepta Genomic Atlas in genomic profiling for lung cancer patients – - Study suggests Envisia classifier can be successfully enabled on nCounter Analysis System - SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Apr. 19, 2021-- Veracyte, Inc .
View HTML
Toggle Summary Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results
Keith Kennedy will retire following Q1 earnings release and 10-Q; Jane Alley appointed as acting CFO; Veracyte to conduct CFO search SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Apr. 15, 2021-- Veracyte, Inc . (Nasdaq: VCYT) announced that Keith Kennedy , chief financial officer and chief
View HTML